Specific probiotic yeast as a tool to reduce the risk of foodborne pathogen contaminations on carcasses of broilers
THE 2 MOST COMMON REPORTED CAUSES OF FOODBORNE DISEASE
To limit the prevalence of bacterial contamination on broiler meat, complementary measures should be applied in the broiler meat supply chain but also on farm
To limit the prevalence of bacterial contamination on broiler meat, complementary measures should be applied in the broiler meat supply chain but also on farm
Evisceration can lead to carcasses microbial contamination
Evisceration can lead to carcasses microbial contamination
Evisceration can lead to carcasses microbial contamination
LEVUCELL SB improves the gut microflora balance and thus helps reduce the risk of foodborne pathogens contamination on the carcasses
LEVUCELL SB improves the gut microflora balance and thus helps reduce the risk of foodborne pathogens contamination on the carcasses
Browse the graph
35 days of age; 21 days Post Infection
38 days of age; 28 days Post Infection
Oral challenge
LEVUCELL SB at commercial recommended dosage
authorized in the EU for the reduction of Salmonella
contamination on carcasses of poultry
20 sec to discover the specific mode of action of LEVUCELL SB
By scavenging oxygen in the digestive tract, LEVUCELL SB limits the growth of undesirable bacteria and supports the development of beneficial ones
“Several clinical trials and experimental studies displayed the role of S. boulardii as a good biotherapeutic agent allowing to prevent and/or treat several gastrointestinal diseases. S. boulardii mediates effects which resemble the protective effects of the normal healthy gut flora.”
Kelesidis T. & Pothoulakis C., 2012
Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders. Therapeutic Advances in Gastroenterology (2012) 5(2) 111–125
• Occasional diarrhea
• Antibiotic associated diarrhea
• Clostridium difficile associated disorders
“Several clinical trials and experimental studies displayed the role of S. boulardii as a good biotherapeutic agent allowing to prevent and/or treat several gastrointestinal diseases. S. boulardii mediates effects which resemble the protective effects of the normal healthy gut flora.”
Kelesidis T. & Pothoulakis C., 2012
Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders. Therapeutic Advances in Gastroenterology (2012) 5(2) 111–125
• Occasional diarrhea
• Antibiotic associated diarrhea
• Clostridium difficile associated disorders
